First Time Loading...
S

Scientific and Medical Equipment House Company CJSC
SAU:4014

Watchlist Manager
Scientific and Medical Equipment House Company CJSC
SAU:4014
Watchlist
Price: 49.7 SAR -5.51% Market Closed
Updated: May 15, 2024

Profitability Summary

Scientific and Medical Equipment House Company CJSC's profitability score is 49/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score
49/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Scientific and Medical Equipment House Company CJSC

Revenue
799.3m SAR
Cost of Revenue
-666.2m SAR
Gross Profit
133.1m SAR
Operating Expenses
-64.1m SAR
Operating Income
69m SAR
Other Expenses
-28.9m SAR
Net Income
40.1m SAR

Margins Comparison
Scientific and Medical Equipment House Company CJSC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SA
Scientific and Medical Equipment House Company CJSC
SAU:4014
1.5B SAR
17%
9%
5%
US
Cigna Group
XMUN:CGN
92.4B EUR
12%
5%
2%
US
Cigna Corp
NYSE:CI
98.5B USD
12%
5%
2%
US
CVS Health Corp
NYSE:CVS
70.1B USD
15%
4%
2%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.8B USD
28%
9%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR
23%
5%
-3%
US
Quest Diagnostics Inc
NYSE:DGX
15.4B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12B EUR
25%
7%
3%
DE
Fresenius Medical Care AG
XMUN:FME
11.8B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
12B USD
32%
14%
7%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
Country SA
Market Cap 1.5B SAR
Gross Margin
17%
Operating Margin
9%
Net Margin
5%
Country US
Market Cap 92.4B EUR
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 98.5B USD
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 70.1B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 17.8B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country DE
Market Cap 16.1B EUR
Gross Margin
23%
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 15.4B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 12B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 11.8B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 12B USD
Gross Margin
32%
Operating Margin
14%
Net Margin
7%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Scientific and Medical Equipment House Company CJSC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SA
Scientific and Medical Equipment House Company CJSC
SAU:4014
1.5B SAR
8%
4%
12%
6%
US
Cigna Group
XMUN:CGN
92.4B EUR
8%
2%
9%
7%
US
Cigna Corp
NYSE:CI
98.5B USD
8%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
70.1B USD
10%
3%
8%
6%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.8B USD
5%
2%
7%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.1B EUR
-3%
-1%
2%
1%
US
Quest Diagnostics Inc
NYSE:DGX
15.4B USD
13%
6%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12B EUR
4%
1%
4%
3%
DE
Fresenius Medical Care AG
XMUN:FME
11.8B EUR
4%
1%
4%
3%
US
DaVita Inc
NYSE:DVA
12B USD
93%
5%
12%
9%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country SA
Market Cap 1.5B SAR
ROE
8%
ROA
4%
ROCE
12%
ROIC
6%
Country US
Market Cap 92.4B EUR
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 98.5B USD
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 70.1B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
6%
Country US
Market Cap 17.8B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 16.1B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 15.4B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 12B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country DE
Market Cap 11.8B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 12B USD
ROE
93%
ROA
5%
ROCE
12%
ROIC
9%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More